𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease?

✍ Scribed by Paolo Liberini; Alessandra Valerio; Maurizio Memo; PierFranco Spano


Book ID
116103819
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
450 KB
Volume
17
Category
Article
ISSN
0165-6147

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Economic evaluation of cholinesterase in
✍ Anders Gustavsson; Rohan Van Der Putt; Linus JΓΆnsson; Rupert McShane πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 2 views

## Abstract ## Objective To assess the cost effectiveness of cholinesterase inhibitor (ChEI) treatment in patients with Alzheimer's disease (AD) and Dementia with Lewy bodies (DLB). ## Method We used 4‐month open label follow‐up data from routine memory clinic patients. There were 852 patients w

Comparison of dementia with Lewy bodies
✍ Enrique Noe; Karen Marder; Karen L. Bell; Diane M. Jacobs; Jennifer J. Manly; Ya πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 2 views

## Abstract We compared the clinical and neuropsychological pattern of dementia with Lewy bodies (DLB) to Alzheimer's disease (AD) and Parkinson's disease with dementia (PD‐d). Sixteen patients clinically diagnosed with DLB were compared with two groups of patients with PD‐d (n = 15) and AD (n = 16